Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALIM | BMY | AMGN | GILD | REGN |
| Company | Alimera Sciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.55 | 47.93 | 265.64 | 67.01 | 901.26 |
| High | 3.66 | 48.20 | 265.92 | 67.02 | 908.81 |
| Low | 3.31 | 47.62 | 263.25 | 65.90 | 891.67 |
| Last | 3.41 | 48.07 | 264.49 | 66.02 | 899.75 |
| Change | -0.14 | +0.23 | +0.42 | -0.91 | -1.44 |
| % Change | -3.94% | +0.48% | +0.16% | -1.36% | -0.16% |
| Volume | 4,401 | 3,180,607 | 453,216 | 2,270,902 | 144,840 |
| 20-Day Average Volume | 67,951 | 11,025,519 | 2,119,531 | 5,991,110 | 417,346 |
| Previous Close | 3.55 | 47.84 | 264.07 | 66.93 | 901.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.80 | 50.98 | 273.05 | 70.20 | 938.93 |
| 20-Day Raw Stochastic | 22.58% | 6.57% | 5.06% | 0.48% | 8.28% |
| 20-Day Relative Strength | 41.83% | 36.13% | 38.22% | 27.48% | 34.28% |
| Weighted Alpha | +25.44 | -30.61 | +5.24 | -25.59 | +12.60 |
| Today's Opinion | 8% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 8% Buy | 56% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 8% Sell | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.57% since 04/11/24 | -2.13% since 04/11/24 | -2.03% since 04/11/24 | -3.92% since 04/11/24 | -2.45% since 04/11/24 |
| Low | 3.31 on 04/18/24 | 47.63 on 04/18/24 | 263.25 on 04/18/24 | 65.92 on 04/18/24 | 890.43 on 04/16/24 |
| High | 3.83 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -12.00% since 03/18/24 | -6.81% since 03/18/24 | -2.35% since 03/18/24 | -9.96% since 03/18/24 | -6.47% since 03/18/24 |
| Low | 3.31 on 04/18/24 | 47.63 on 04/18/24 | 263.25 on 04/18/24 | 65.92 on 04/18/24 | 890.43 on 04/16/24 |
| High | 4.24 on 03/25/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -9.51% since 01/18/24 | -4.02% since 01/18/24 | -13.12% since 01/18/24 | -23.66% since 01/18/24 | -3.46% since 01/18/24 |
| Low | 3.07 on 02/21/24 | 47.58 on 02/06/24 | 263.25 on 04/18/24 | 65.92 on 04/18/24 | 890.43 on 04/16/24 |
| High | 4.27 on 03/15/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +21.38% since 10/18/23 | -15.44% since 10/18/23 | -6.72% since 10/18/23 | -17.21% since 10/18/23 | +8.69% since 10/18/23 |
| Low | 2.83 on 10/19/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.92 on 04/18/24 | 769.19 on 10/27/23 |
| High | 4.38 on 01/02/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 185,857 | 96,960,152 | 141,520,144 | 83,333,008 | 98,916,416 |
| Shares Outstanding, K | 52,354 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 80,750,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -20,130,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 26,310,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -3,780,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.18 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 03/07/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 23.79 |